The Centers for Medicare & Medicaid Services today issued guidance on designing state approaches to covering treatment services for Medicaid-eligible infants with neonatal abstinence syndrome. “Through discussions with states, we have recognized their growing challenge in providing treatment services to the expanding number of infants with NAS,” said Tim Hill, acting director of the Center for Medicaid and CHIP Services. “We have also recognized that states may not be fully aware of available options under Medicaid that can play a critical role in the care of these infants, as well as the limitations on Medicaid coverage.” In addition, CMS issued a letter to state Medicaid directors on funding authorities that may support health information technology efforts to address the opioid crisis.

Related News Articles

Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
The Centers for Medicare & Medicaid Services today announced a nationwide initiative aimed at reinforcing eligibility standards for Medicaid and the…
Headline
The Cybersecurity and Infrastructure Security Agency, Environmental Protection Agency, National Security Agency, FBI and international agencies Aug. 13…
Headline
The Trump administration Aug. 13 issued an executive order revoking a 2021 order by the previous administration that established a “whole-of-government” effort…
Headline
The Centers for Medicare & Medicaid Services has issued the 2025-2026 Medicaid Managed Care Rate Development Guide for states to use when setting managed…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…